高级检索
当前位置: 首页 > 详情页

Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by sulforaphane through the activation of Nrf2 nuclear translocation

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Deparment of Emergency, the People's Hospital of Guang Du District, Kunming 650200 [2]The Second Deparment of Internal Medicine, the People's Hospital of Panlong District, Kunming 650021 [3]Mental Health Hospital of Prevention and Treatment in Kunming City, Kunming 650041 [4]Department of Anesthesiology,Kunhua Hospital, the First People's Hospital of Yunnan Province, Kunming 650032, P.R. China
出处:
ISSN:

关键词: 6-hydroxydopamine endoplasmic reticulum sulforaphane Parkinson's disease

摘要:
Endoplasmic reticulum (ER) stress plays a key role in the development of neurodegenerative diseases, including Parkinson's disease (PD). Sulforaphane (SF) is a natural drug derived from isothiocyanate found in cruciferous vegetables. Although there are reports indicating that SF is a potential candidate for PD treatment, there have been no reports on the effects of SF on ER stress in PD. In this study, we investigated the cytoprotective effects of SF on 6-hydroxydopamine (6-OHDA)-induced ER stress in rat PC12 cells. Pre-treatment with SF elicited cytoprotection against 6-OHDA-induced cytotoxicity. Consistent with its cytoprotective action, SF significantly inhibited subsequent ER stress, including the expression of Bip and the C/EBP homologous protein. We also found that transfection with NF-E2-related factor-2 (Nrf2) siRNA reversed the inhibitory effects of SF on 6-OHDA-induced ER stress responses. In conclusion, our results show that SF can prevent ER stress response induced by 6-OHDA through the activation of Nrf2. SF may be a therapeutic candidate for the treatment of ER stress-associated neural diseases, including PD.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2011]版:
Q4 ONCOLOGY Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q2 ONCOLOGY Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者机构: [1]Deparment of Emergency, the People's Hospital of Guang Du District, Kunming 650200
通讯作者:
通讯机构: [4]Department of Anesthesiology,Kunhua Hospital, the First People's Hospital of Yunnan Province, Kunming 650032, P.R. China [*1]Department of Anesthesiology, Kunhua Hospital, the First People's Hospital of Yunnan Province, Kunming 650032, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82325 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号